What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0001704268
Total reported value
$34.8B
$34.8B
14 檔
53.5%
At the close of Q3 2024, Mubadala Investment Co PJSC disclosed equity holdings valued at approximately $34.8B, spread across 14 reported holdings.
In Q3 2024, Mubadala Investment Co PJSC adopted a defensive or profit-taking posture, trimming 2 positions and completely liquidating 5 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GFS | GLOBALFOUNDRIES Inc. | Stock-Tech | 96.27% | +2.87% | -4.07% | |
| 2 | ARM | Arm Holdings Plc-adr | Stock-Tech | 1.14% | -0.10% | — | |
| 3 | CERT | Certara Inc | Stock-Other | 0.60% | — | — | |
| 4 | RXRX | Recursion Pharmaceuticals-a | Stock-Healthcare | 0.45% | — | — | |
| 5 | ARIS | Aris Mining CORP | Stock-Other | 0.38% | -0.09% | — | |
| 6 | NEXT | Nextdecade CORP | Stock-Other | 0.36% | -0.22% | — | |
| 7 | 0C3 | Endeavor Group Hold-class A | Stock-Other | 0.34% | — | — | |
| 8 | TWKSEUR | Thoughtworks Holding Inc | Stock-Other | 0.18% | — | — | |
| 9 | CPNG | Coupang Inc | Stock-Consumer Disc | 0.13% | — | -30.00% | |
| 10 | EVO | Evotec Se - Spon Adr | Stock-Other | 0.09% | -0.06% | EXIT | |
| 11 | NBIS | Nebius Group N.V. | Stock-Other | 0.05% | — | — | |
| 12 | OMGBP | Outset Medical Inc | Stock-Other | 0.01% | — | — | |
| 13 | EVAUSD | Enviva Inc | Stock-Other | — | — | — | |
| 14 | ✓ | Gdev Inc | Stock-Other | — | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | GFS | GLOBALFOUNDRIES Inc. | +0.3% | -4.07% | Trim |
| 2 | ARM | Arm Holdings Plc-adr | +0.2% | — | Unchanged |
| 3 | ARIS | Aris Mining CORP | +0.1% | — | Unchanged |
| 4 | 0C3 | Endeavor Group Hold-class A | +0.1% | — | Unchanged |
| 5 | TWKSEUR | Thoughtworks Holding Inc | +0.1% | — | Unchanged |
| 6 | CERT | Certara Inc | +0.1% | — | Unchanged |
| 7 | RXRX | Recursion Pharmaceuticals-a | +0.1% | — | Unchanged |
| 8 | CPNG | Coupang Inc | 0% | -30.00% | Trim |
| 9 | NBIS | Nebius Group N.V. | 0% | — | Unchanged |
| 10 | EVO | Evotec Se - Spon Adr | — | — | Unchanged |
| 11 | EVAUSD | Enviva Inc | — | — | Unchanged |
| 12 | ✓ | Gdev Inc | — | — | Unchanged |
| 13 | OMGBP | Outset Medical Inc | 0% | — | Unchanged |
| 14 | DELL | Dell Technologies -c | 0% | EXIT | Sold out |
| 15 | RVMD | Revolution Medicines Inc | 0% | EXIT | Sold out |
| 16 | DOCN | Digitalocean Holdings Inc | -0.1% | EXIT | Sold out |
| 17 | NEXT | Nextdecade CORP | -0.1% | — | Unchanged |
| 18 | DLR | Digital Realty Trust Inc | -0.1% | EXIT | Sold out |
| 19 | YMM | Full Truck Alliance -spn Adr | -0.6% | EXIT | Sold out |
According to official SEC Form 13F filings, Mubadala Investment Co PJSC reported a total U.S. public equity portfolio value of $34.8B across 14 disclosed positions in Q3 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including GFS, ARM, CERT) accounted for 53.5% of total reported equity market value during Q3 2024.
Top Position Liquidated / Trimmed
YMM
前期市值: $134.9M
During Q3 2024, Mubadala Investment Co PJSC's top holdings by market value included GFS (96.3%)、ARM (1.1%)、CERT (0.6%). The largest single position, GFS, represented 96.3% of total portfolio value.
In Q3 2024, Mubadala Investment Co PJSC made 7 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 2 holdings, and fully liquidating 5 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.